Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 881 Neoplasms 668 Prostatic Neoplasms 455 Lung Neoplasms 368 Colorectal Neoplasms 335 Carcinoma, Non-Small-Cell Lung 320 Leukemia, Myeloid, Acute 257 Pancreatic Neoplasms 224 Brain Neoplasms 210 Multiple Myeloma 204 Neoplasm Metastasis 201 Carcinoma, Hepatocellular 184 Head and Neck Neoplasms 183 Glioblastoma 170 Precursor Cell Lymphoblastic Leukemia-Lymphoma 169 Melanoma 159 Ovarian Neoplasms 158 Squamous Cell Carcinoma of Head and Neck 152 Recurrence 139 Rectal Neoplasms 137 Hematologic Neoplasms 130 Sarcoma 126 Uterine Cervical Neoplasms 124 Stomach Neoplasms 118 Carcinoma, Renal Cell 118 Triple Negative Breast Neoplasms 116 Glioma 116 Motor Activity 105 Urinary Bladder Neoplasms 100 Myelodysplastic Syndromes 99

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chalazion × 90 days × Clear all

NCT07496515 2026-03-27

CH01

Jaeb Center for Health Research

Phase 2 Not yet recruiting

Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡